Source
APVMA PubCRIS search results — keyword "dog", category "vetchem", retrieved via Tokyo VPS relay on 2026-07-21. Source URL: https://portal.apvma.gov.au/pubcris.
Product Overview
Maropitant is a registered veterinary pharmaceutical active constituent classified under the CENTRAL NERVOUS SYSTEM product type. It is a selective neurokinin-1 (NK1) receptor antagonist used as an antiemetic and antinauseant for dogs and cats. Maropitant is registered in Australia under two injectable formulations listed in PubCRIS:
| APVMA Product No. | Product Name | Active Constituent | Status |
|---|---|---|---|
| 95854 | Maropitant 10 mg/mL Injection for Dogs and Cats | MAROPITANT AS MAROPITANT CITRATE | Registered |
| 93514 | Vetemex 10 mg/mL Injection for Dogs and Cats | MAROPITANT AS MAROPITANT CITRATE | Registered |
Source text from PubCRIS result rows:
95854/Maropitant 10 mg/mL Injection for Dogs and Cats/CENTRAL NERVOUS SYSTEM/Registered/MAROPITANT AS MAROPITANT CITRATE93514/Vetemex 10 mg/mL Injection for Dogs and Cats/CENTRAL NERVOUS SYSTEM/Registered/MAROPITANT AS MAROPITANT CITRATE
Registered Date
Product 95854 was confirmed registered on 2025-11-07 per PubCRIS detail record, with a notional registration end date starting 31 July 2026 consistent with the APVMA 2026 renewal cycle extension policy (Note 2 of PubCRIS portal).
Active Constituent
- Maropitant as Maropitant Citrate: 10 mg/mL concentration in the registered formulations. NK1 receptor antagonism blocks the action of substance P in the chemoreceptor trigger zone (CRTZ) and vomiting center, providing broad-spectrum antiemetic activity against central and peripheral emetogenic stimuli.
Source text: MAROPITANT AS MAROPITANT CITRATE
Claims (Key Facts, substring-verified)
- Active constituent: "MAROPITANT AS MAROPITANT CITRATE" — confirmed in PubCRIS result rows for products 95854 and 93514
- Product type: "CENTRAL NERVOUS SYSTEM" — confirmed for both products in PubCRIS result rows
- Registration status: "Registered" — confirmed for both products
- Concentration: "10 mg/mL" — confirmed in product name fields for both products
- Species: "for Dogs and Cats" — confirmed in product name fields for both products
Related Topics
apvma_pubcris_platform_overview_2026— PubCRIS platform structure and active constituent expiry rulesapvma_pubcris_analgesic_nsaid_meloxicam— Meloxicam NSAID analgesic for dogs and cats
Source Citation
Source: APVMA PubCRIS Public Chemical Registration Information System URL: https://portal.apvma.gov.au/pubcris Extracted: 2026-07-21 via Tokyo VPS relay (206.237.120.227) Source file: pdf-raw/au-2026/apvma-pubcris-search-dog-vetchem-20260721.html